Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albuterol Spiromax in Persistent Asthma
NCT01747629Phase 3Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Dec 2012
- Primary completion
- Oct 2013
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of albuterol spiromax in asthma, sponsored by Teva Pharmaceutical Industries Ltd.. Started Dec 2012; status: completed.
02
Drugs
albuterol spiromax
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01747629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01747629.